关注
Kogieleum Naidoo
Kogieleum Naidoo
Head: Treatment Research Programme, CAPRISA
在 caprisa.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Timing of initiation of antiretroviral drugs during tuberculosis therapy
SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ...
New England Journal of Medicine 362 (8), 697-706, 2010
9212010
Treatment of highly drug-resistant pulmonary tuberculosis
F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ...
New England Journal of Medicine 382 (10), 893-902, 2020
7812020
Integration of antiretroviral therapy with tuberculosis treatment
SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ...
New England Journal of Medicine 365 (16), 1492-1501, 2011
6482011
Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection
PK Drain, KL Bajema, D Dowdy, K Dheda, K Naidoo, SG Schumacher, ...
Clinical microbiology reviews 31 (4), 10.1128/cmr. 00021-18, 2018
4962018
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression …
RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ...
The Lancet infectious diseases 18 (3), 346-355, 2018
4282018
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
N Dookie, S Rambaran, N Padayatchi, S Mahomed, K Naidoo
Journal of Antimicrobial Chemotherapy 73 (5), 1138-1151, 2018
3352018
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial
K Naidoo, N Yende-Zuma, N Padayatchi, K Naidoo, N Jithoo, G Nair, ...
Annals of internal medicine 157 (5), 313-324, 2012
1512012
Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy
V Naranbhai, AVS Hill, SS Abdool Karim, K Naidoo, Q Abdool Karim, ...
The Journal of infectious diseases 209 (4), 500-509, 2014
1432014
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ...
Scientific reports 10 (1), 8629, 2020
1152020
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ...
The Lancet Infectious Diseases 21 (3), 354-365, 2021
1142021
Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
J Dorward, R Lessells, PK Drain, K Naidoo, T de Oliveira, Y Pillay, ...
The lancet HIV 5 (7), e400-e404, 2018
1102018
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?
EP Hyle, K Naidoo, AE Su, WM El-Sadr, KA Freedberg
JAIDS Journal of Acquired Immune Deficiency Syndromes 67, S87-S95, 2014
962014
Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study
A Moosa, TN Gengiah, L Lewis, K Naidoo
BMC infectious diseases 19, 1-12, 2019
942019
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised …
MC Hosseinipour, GP Bisson, S Miyahara, X Sun, A Moses, C Riviere, ...
The Lancet 387 (10024), 1198-1209, 2016
942016
Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial
PK Drain, J Dorward, LR Violette, J Quame-Amaglo, KK Thomas, ...
The lancet HIV 7 (4), e229-e237, 2020
912020
High prevalence of hookah smoking among secondary school students in a disadvantaged community in Johannesburg: scientific letters
A Combrink, N Irwin, G Laudin, K Naidoo, S Plagerson, A Mathee
South African Medical Journal 100 (5), 297-299, 2010
852010
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study
JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ...
The lancet HIV 8 (2), e87-e95, 2021
842021
Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis
B Chimukangara, RJ Lessells, SY Rhee, J Giandhari, ABM Kharsany, ...
EClinicalMedicine 9, 26-34, 2019
762019
Tuberculosis-HIV co-infection: progress and challenges after two decades of global antiretroviral treatment roll-out
E Letang, J Ellis, K Naidoo, EC Casas, P Sánchez, R Hassan-Moosa, ...
Archivos de bronconeumologia 56 (7), 446-454, 2020
752020
When to start antiretroviral therapy during tuberculosis treatment?
K Naidoo, C Baxter, SSA Karim
Current opinion in infectious diseases 26 (1), 35-42, 2013
752013
系统目前无法执行此操作,请稍后再试。
文章 1–20